A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
NCT04205916
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Patient Preference
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 22 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Ophthalmic Consultants of Long Island
- Last updated on ClinicalTrials.gov
- December 20, 2019
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Ophthalmic Consultants of Long Island · Garden City, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.